Literature DB >> 8929952

A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype.

B A Evans1, D J Bowen, P J Smith, P E Clayton, J W Gregory.   

Abstract

Genomic DNA from two families with male limited precocious puberty was examined for mutations of the LH receptor gene. In family 1, several members of the pedigree have FMPP, whereas in family 2 there is only one affected subject. A point mutation (T --> C at nucleotide 1192) resulting in substitution of threonine for methionine 398 in the second transmembrane domain of the LH receptor protein was found in both families. In addition, one member of family 1 has the mutation, but no evidence of precocious puberty. All obligate carriers within this family were shown to have the mutation, and it was not detected in 94 chromosomes from unaffected and unrelated white subjects. In family 2, the index case was the only one to have the mutation. A previously unreported neutral dimorphism (C --> T at nucleotide 1065) is also described.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929952      PMCID: PMC1051841          DOI: 10.1136/jmg.33.2.143

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Constitutively active mutants of rhodopsin.

Authors:  P R Robinson; G B Cohen; E A Zhukovsky; D D Oprian
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

Review 2.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  Cloning and sequencing of human LH/hCG receptor cDNA.

Authors:  T Minegishi; K Nakamura; Y Takakura; K Miyamoto; Y Hasegawa; Y Ibuki; M Igarashi; T ] Minegish T [corrected to Minegishi
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

4.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

5.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.

Authors:  J Parma; L Duprez; J Van Sande; P Cochaux; C Gervy; J Mockel; J Dumont; G Vassart
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

6.  Structure of the luteinizing hormone receptor gene and multiple exons of the coding sequence.

Authors:  Y B Koo; I Ji; R G Slaughter; T H Ji
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

7.  A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.

Authors:  K Yano; M Saji; A Hidaka; N Moriya; A Okuno; L D Kohn; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

8.  Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function.

Authors:  L S Robbins; J H Nadeau; K R Johnson; M A Kelly; L Roselli-Rehfuss; E Baack; K G Mountjoy; R D Cone
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

9.  Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.

Authors:  S M Rosenthal; M M Grumbach; S L Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

10.  Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.

Authors:  J A Batch; D M Williams; H R Davies; B D Brown; B A Evans; I A Hughes; M N Patterson
Journal:  Hum Mol Genet       Date:  1992-10       Impact factor: 6.150

View more
  10 in total

Review 1.  Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors.

Authors:  A C Latronico; D L Segaloff
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

Review 2.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

Review 3.  Mutations in human gonadotropin and gonadotropin-receptor genes.

Authors:  I T Huhtaniemi; A P N Themmen
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

5.  Severe testotoxicosis phenotype associated with Asp578-->Tyr mutation of the lutrophin/choriogonadotrophin receptor gene.

Authors:  J Müller; B Gondos; S Kosugi; T Mori; A Shenker
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

Review 6.  Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.

Authors:  Ana Claudia Latronico; Deborah L Segaloff
Journal:  Mol Cell Endocrinol       Date:  2006-10-18       Impact factor: 4.102

Review 7.  Phenotypic diversity in siblings with partial androgen insensitivity syndrome.

Authors:  B A Evans; I A Hughes; C L Bevan; M N Patterson; J W Gregory
Journal:  Arch Dis Child       Date:  1997-06       Impact factor: 3.791

8.  Study of the family of a patient with male-limited precocious puberty (MPP) due to T1193C transition in exon 11 of LH receptor gene.

Authors:  M Ignacak; J Starzyk; H Dziatkowiak; W H Trzeciak
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

9.  Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty.

Authors:  Xin Yuan; Ruimin Chen; Ying Zhang; Xiaohong Yang; Xiangquan Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

10.  How genetic errors in GPCRs affect their function: Possible therapeutic strategies.

Authors:  Henriette Stoy; Vsevolod V Gurevich
Journal:  Genes Dis       Date:  2015-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.